Tenax Therapeutics Inc reports results for the quarter - Earnings Summary

Tenax Therapeutics

13/11/2024 14:16

* Tenax Therapeutics Inc  TENX.OQ  reported a quarterly
adjusted
loss of 19 cents​​ per share for the quarter , higher than the
same quarter last year, when the company reported EPS of
$-6.40.  The mean expectation of five analysts for the quarter
was for a loss of $1.39 per share. Wall Street expected
results to range from $-1.62 to $-1.16 per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Tenax Therapeutics Inc's reported EPS for the quarter was
a loss
of 19 cents​.
    * The company reported a quarterly loss of $3.96 million.
    * Tenax Therapeutics Inc shares had risen by 41.6% this
quarter and lost 77.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 1.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "strong buy"

Wall Street's median 12-month price target for Tenax
Therapeutics Inc is 16.00 
This summary was machine generated from LSEG data November 13 at
02:16 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2024      -1.39          -0.19          Beat
 Jun. 30 2024      -1.98          -1.83          Beat
 Mar. 31 2024      -2.40          -3.12          Missed
 Dec. 31 2023      -8.14          -12.98         Missed